Episode
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
- Podcast
- Hematologic Oncology Update
- Published
- Dec 11, 2025
- Duration seconds
- 3510
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/car-t-cell-therapy-for-non-hodgkin-lymphoma-cancer-q-a-discussing-common-questions-posed-by-patients.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here .